Centene Corp will promote its synthetic intelligence-powered healthcare analytics platform Apixio to funding agency New Mountain Capital as a part of an ongoing portfolio evaluation, the U.S. well being insurer stated on Wednesday.
The firm, which acquired Apixio in December 2020, didn’t disclose the phrases of the transaction.
Apixio compiles and analyzes massive volumes of unstructured affected person knowledge, together with medical charts and doctor’s notes, into insights and curated knowledge.
“As part of our ongoing portfolio review, it was important for us to find a strategic partner for Apixio with whom the business can continue to grow,” stated Centene Chief Executive Office Sarah London stated in a press release.
Centene stated it expects the sale of the platform to be impartial to its adjusted revenue for this yr.
Stay on prime of expertise and startup news that issues. Subscribe to our every day publication for the most recent and must-read tech news, delivered straight to your inbox.
Source: economictimes.indiatimes.com